Synapse - Linda Marks

About
FAQ
Reports
Contact Us

Works
Groups
People
Publications
Publishers

Search Within

Linda Marks

Home
Works
Groups

"Investigational New Drugs"

Formats

Journal Article (2)

Groups

Department of Medicine (1)
Solid Tumor Oncology Division (1)
Thoracic Oncology (1)

People

Edgar Cheng (1)
Ephraim Casper (1)
Gordon Magill (1)
James Rigas (1)
Mark Kris (1)
Matthew Carabasi (1)

Edgar Cheng (1)
Ephraim Casper (1)
Gordon Magill (1)
James Rigas (1)
Mark Kris (1)
Matthew Carabasi (1)
Richard Gralla (1)
Robert Heelan (1)

Years

1992 (1)
1991 (1)

Publications

Investigational New Drugs (2)

Publishers

Springer (2)

Results (2)

Export to EndNote / Excel | PubMed

Show: Sort By: Order: Style:

Citation style sort is year ascending, and then by author or title. Author ascending is default.

Oral piritrexim: A phase II study in patients with advanced soft tissue sarcoma

Journal Article

Schiesel, J. D.; Carabasi, M.; Magill, G.; Casper, E.; Cheng, E.; Marks, L.; Feyzi, J.; Clendeninn, N. J.; Smalley, R. V.
Investigational New Drugs (1992)

Fulltext@MSK | Save

Phase II trial of esorubicin (4′ deoxydoxorubicin, DxDx) in patients with small cell lung cancer

Journal Article

Rigas, J. R.; Kris, M. G.; Gralla, R. J.; Heelan, R. T.; Marks, L. D.
Investigational New Drugs (1991)

Fulltext@MSK | Save

Memorial Sloan Kettering Cancer Center | Memorial Hospital for Cancer and Allied Diseases | Sloan Kettering Institute

Gerstner Sloan Kettering Graduate School of Biomedical Sciences Patients & Caregivers

Legal Disclaimer | Giving to the Library

© 2025 Memorial Sloan Kettering Cancer Center Library